直 Japanese PDF Font
  • Our Professionals
  • Our Work
  • Our Insights
  • Offices
  • Firm
  • Careers
Finnegan
  • Articles & Books
    • Ad Law Buzz Blog
    • At the PTAB Blog
    • European IP Blog
    • Federal Circuit IP Blog
    • INCONTESTABLE® Blog
    • Prosecution First Blog
  • Events & Webinars
  • IP Updates
  • Podcasts
    • AI + Finnegan
    • AI + Copyright
    • AI + Patent
    • AI + Privacy
    • AI + Trade Secrets
    • AI + Trademark
  • Unified Patent Court (UPC) Hub

At the PTAB Blog

Top Five Provisions in the PATENT Act Impacting AIA Post-Grant Proceedings

June 12, 2015

Authored and Edited by C. Brandon Rash

On June 4, 2015, the Senate Judiciary Committee approved the patent reform bill known as the PATENT Act. While the Act includes provisions affecting patent litigation in district courts, such as fee-shifting measures and new pleading standards, it also impacts AIA post-grant proceedings before the USPTO.  Here are the top five provisions affecting AIA proceedings:

  1. Changing the Claim Construction Standard - Although the USPTO has traditionally applied the “broadest reasonable interpretation” standard, the Act applies the Phillips standard used by district courts to interpret claims as they would be understood by a person of ordinary skill in the art. The USPTO would also have to consider any prior district court constructions, and each party would be bound in subsequent proceedings by claim construction positions that the USPTO adopts.
  1. Improving the Institution Decision - The Act allows a patent owner to submit new testimonial evidence with its preliminary response and allows the petitioner to seek leave to reply to new issues raised in the preliminary response. Also, the panel adjudicating the AIA proceeding would include no more than one judge who participated in the institution decision.
  1. Applying One-Year Time Bar for IPRs on Claim-by-Claim Basis - Under the AIA, a petitioner may not file a petition more than one year after being served with a complaint alleging infringement of the patent. The Act precludes institution only on those patent claims for which infringement is alleged.
  1. Allowing Live Testimony - The Act gives parties the right to have testimony, including cross examination, heard by the USPTO where the testimony concerns genuine issues of material fact, conflicting expert opinions, or issues of witness credibility.
  1. Preventing Gamesmanship - The Act requires the USPTO to impose obligations on attorneys and unrepresented parties similar to Rule 11 of the Federal Rules of Civil Procedure. The USPTO would also be able to deny institution if institution would not serve the “interests of justice,” including such factors as whether the grounds of unpatentability are substantially the same as those in prior district court or USPTO proceedings and whether there is a pending USPTO proceeding involving the same patent.

The Act also includes other provisions such as “placeholder language” for changes to claim amendments requiring proposed amendments to be made in the first paper following, and within 30 days after, institution. The amendment would have to narrow the claim and respond to a ground of unpatentability. The burden to show that the substitute claim is unpatentable would be a preponderance of the evidence.

 

Tags

claim construction, Protecting American Talent and Entrepreneurship (PATENT) Act, patent reform

Related Practices

Patent Office Invalidation Proceedings

PTAB Invalidation Proceedings: IPR and PGR

Copyright © 2015 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP. 

DISCLAIMER: Although we wish to hear from you, information exchanged in this blog cannot and does not create an attorney-client relationship. Please do not post any information that you consider to be personal or confidential. If you wish for Finnegan, Henderson, Farabow, Garrett & Dunner, LLP to consider representing you, in order to establish an attorney-client relationship you must first enter a written representation agreement with Finnegan. Contact us for additional information. Additional disclaimer information. 

Related Insights

Conference

7th International Conference on Biofuels and Bioenergy

June 25-26, 2026

Edinburgh

Conference

IPBC Global 2026

June 15-17, 2026

San Diego

Conference

2026 Copyright Society Annual Meeting

June 14-16, 2026

Louisville

Conference

17th Summit on Biosimilars & Innovator Biologics

June 2-3, 2026

New York

At the PTAB Blog

Consistency Is Key – USPTO Issues Three New Informative Decisions

May 29, 2026

At the PTAB Blog

Discretion All the Way Down: USPTO Uses a Discretionary IPR Denial to Justify a    
§ 325(d) EPR Denial

May 28, 2026

Articles

Colorado Replaces Landmark AI Act: An Overview of the New SB 26-189 Framework

May 26, 2026

At the PTAB Blog

Claim Disclaimer Derails Instituted IPR in Freightcar America

May 26, 2026

At the PTAB Blog

IPR and PGR Statistics for Final Written Decisions Issued in March and April 2026

May 26, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • Privacy
  • Disclaimer
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP